TODAY -

Transforming hope into reality for patients of drug-resistant TB

Shobha Shukla *



Multidrug-resistant TB (MDR-TB) remains a public health crisis. As per WHO's Global TB Report 2016, 480,000 people fell ill with MDR-TB in 2015, with 3 countries – India, China, and Russia – carrying the major burden and together accounting for nearly half of all MDR-TB cases globally.

Detection and treatment gaps continue to plague the MDR-TB response. In 2015, only 1 out of every 5 people needing treatment for MDR-TB were able to access it and only 52% of those who started MDR-TB treatment were cured.

"These sobering statistics remind us of our urgency to continue the fight to develop better, faster and affordable treatments that will finally bring this pandemic under control," said Dr Mel Spigelman, CEO of TB Alliance, which is working to advance several promising regimens to tackle all forms of TB.

The current MDR-TB regimen lasts for 2 years or more. It includes medicines and injectables that are not only toxic but also come at a cost that is higher than what many patients and healthcare systems can afford. Even the new 9 month MDR-TB regimen that has recently been endorsed by WHO, though shorter, does include 4 months of injectables.

However new results from 2 clinical studies conducted by TB Alliance point to an emerging paradigm, where countries may soon have the short, all-oral, and affordable drug regimens needed to treat all people with TB. Late stage clinical results from these two studies were unveiled yesterday at the 47th Union World Conference on Lung Health in Liverpool.

The NC-005 study

The NC-005 study investigates an oral, injection free regimen that purports to treat both drug-sensitive and MDR-TB with a short, simple, safe, and affordable treatment. A Phase 2b, 2 month study tested various combinations of BPaMZ—Bedaquiline (B), Pretomanid (Pa), Moxifloxacin (M) and Pyrazinamide (Z). It was conducted at 10 sites in 3 countries (Uganda, South Africa, and Tanzania).

A total of 240 patients were enrolled in the study— 180 patients with drug-sensitive TB received BPaZ and 60 patients with MDR-TB received BPaMZ. The study also investigated a simpler dosing scheme for bedaquiline, which could lead to fewer pills and an overall less complicated treatment for patients.

NC-005 showed that the best regimen was a combination of all four drugs, BPaMZ, which was examined in an arm of the trial. Data showed that at the end of 2 months, clinical study participants receiving BPaMZ cleared TB bacteria from their sputum 3 times as quickly as those on the standard treatment regimen. Almost all participants had culture conversion after the 2 months of treatment.

This is the fastest rate of culture conversion that has ever been seen and indicates the potential of BPaMZ to treat all forms of TB-drug-sensitive as well as MDR-TB with the same regimen. The regimens appeared safe. The study showed that it was possible to simplify the dosing of Bedaquiline and found that a daily dose of Bedaquiline (200 mg) is at least as active and safe as the labelled dose. This will allow for simpler daily dosing with the regimen and to be combined in a fixed dose combination.

The BPaMZ regimen is being tested to see if it can cure the vast majority of TB patients in as less as 3 months. If successful, the regimen could reshape the treatment landscape of TB, especially for people with MDR-TB, who currently face an arduous 9-24 month treatment journey that is too often unsuccessful. The results of NC-005 could pave the way to a global Phase 3 trial.

The Nix-TB Study
('Nix' means to put an end to)

It is estimated that 9% of all the MDR-TB patients suffer from extensively drug-resistant TB (XDR-TB) that is resistant to at least four commonly used anti-TB drugs. XDR-TB is often considered a death sentence. Most XDR-TB is not treated at all because of the cost and complexity of the treatment. Of those who do receive treatment, less than one third get cured.

In May 2015, TB Alliance and partners launched the world's first clinical study— the Nix-TB Study-to test a new XDR-TB drug regimen called BPaL, consisting of Bedaquiline (B), Pretomanid (Pa), and Linezolid (L) in patients who have no other treatment options. It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB.

Nix-TB is an open-label study that is being conducted at 2 sites in South Africa—at Sizwe Hospital in Johannesburg and at Brooklyn Chest Hospital in Cape Town. Additional sites to expand the study are planned.

Patients who have XDR-TB, or have failed their current MDR-TB treatment or who have side effects of their current MDR-TB treatment, are enrolled.Till to date, 50 patients have been enrolled in the study, including patients as young as 14 and those who are co-infected with HIV with a CD4 cell count of 50 or higher.

Initial data from the study shows the promise of BPaL to treat XDR-TB in only 6 months – Bedaquiline (400 mg daily for 2 weeks followed by 200 mg twice a week), Pretomanid (200 mg daily) and Linezolid (1200 mg daily) given orally for 6 months with the option to extend treatment to 9 months for participants who do not culture convert within 4 months. Patients are assessed at regular intervals with the aim of being cured in 6 months. After completing treatment, participants will be monitored for two years to ensure they do not relapse.

The interim results (between April 2015 and July 2016) on the first 15 participants enrolled in the study, of whom 7 were HIV positive, showed that 12 of them completed 6 months of therapy. The majority were culture negative by week 8 and no patient needed an extension of treatment. As of July 1, 2016 there have been no clinical or micro biological relapses.

As of now, 30 patients have completed 6 months of treatment and all have negative cultures of their sputum. There have been no relapses to date, although the study is still ongoing. The rest of the patients are in various stages of treatment and follow-up. 4 patients have died, but this is a substantially lower mortality than ever reported before.

The early results of this greatly simplified and shortened all oral regimen for XDR-TB appear to be encouraging in terms of both efficacy and safety. The regimen appears safe but requires medical supervision. Linezolid, which has been used off-label to treat MDR-TB, has considerable toxicity but was managed in a clinical study setting.

This is the first injection-free regimen for XDR-TB that, if successful, could transform XDR-TB treatment, with patients being cured by taking a relatively short, simple, oral and effective regimen. Importantly, the regimen would also reduce the complexity and cost of the treatment to a fraction of what it is today, facilitating the global implementation of XDR-TB treatment in resource-poor nations.

These regimens can be deployed in the context of currently available or forthcoming diagnostics. These regimens may revolutionise and markedly reshape the treatment landscape for TB by offering a common therapy for virtually all people with drug-sensitive and drug-resistant TB, and a closely related treatment for those with extensively drug-resistant TB.


* Shobha Shukla (Citizen News Service (CNS)) wrote this article for e-pao.net
Shobha Shukla is providing thematic coverage from the 47th Union World Conference on Lung Health, Liverpool, United Kingdom, with kind support from TB Alliance (Global Alliance for TB Drug Development). Follow her on Twitter @Shobha1Shukla
This article was posted on November 02, 2016.


* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of e-pao.net. We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.




LATEST IN E-PAO.NET
  • The Great June 18 Uprising :: Sub-Site
  • Zeliangrong settlement at Heibokching #1
  • Mind Mapping
  • Virtual Assistant as career option
  • Environmental bio pollution in Manipur
  • Parenting - A challenge in modern time
  • From June 18, 2001 to June 18, 2019
  • Revolt by dissidents is a lesson for CM
  • The Great June 18 Uprising :: Flash
  • Bishnupriya Manipuri: Identity : Book
  • The Rain-Clad Skies of Imphal : Poem
  • Healthy ageing & screening tests
  • Adaptability to quality will boost Education
  • Greencane Industries
  • Staring at political & financial crisis
  • Indo-Myanmar ops on rebel camps
  • Chayom Thupki (Meetei Philosophy) #4
  • Eyek Tamba :: Learn Manipuri script
  • The Story of Two Incidents in One State
  • Cry of a Dying River - 80 : Poem
  • Combating climate change
  • Idea of selling seized liquor
  • Mutum Somorjit : Passed IIT Main/Advance
  • Chak-tangba, Overdraft & Game of Throne
  • Poumai Paoki Wrestling #1: Gallery
  • AEKo_Igi wari :: Seireng
  • Pettigrew contribution to Tribal practice #1
  • Man in White (MIW)
  • India Influence Report 2019
  • Skin care essentials for dry skin
  • Rejoinder to NDPP :: NPF [14 Jun]
  • Far removed from Cong Mukt slogan
  • Taming the traffic
  • Tolloi, Ukhrul :: 360 Panorama View
  • Heritage Park #1 : Gallery
  • Daniel Chabungbam in 7 best NE Journalist
  • Bamboo as a green gold bioresource
  • Inner Line Permit (ILP) Demand :: Timeline
  • Her Fantasy :: Poem
  • NDPP communique on NPF President
  • Pedagogy for 21st Century Teaching
  • Media Sensitization Workshop on Hepatitis
  • Taking back to 1999: Of overdraft & politics
  • The battle for the Throne
  • Lai Lamthokpa, Thangjing #3: Gallery
  • Invisible workforce: The domestic worker
  • Manipur - An Ethnic Dilemma #2
  • Contemporary issues in Mizoram : Book
  • Modern village administration #2
  • Mitigating hunger is only choice of a poor
  • Digitisation & Cyber Security Training
  • Disturbing dissent within the BJP
  • Id-ul-Fitr @ Hatta #2 : Gallery
  • An evening with Manipuri dance
  • Finally some semblance of awareness
  • Nationalism in Manipuri literature #3
  • Sail Away With Me :: Poem
  • World Music Day at Yaiskul, Imphal
  • Selected candidates to the Global Shapers
  • India-Myanmar conf: Better late than never
  • Thangjing Lai Haraoba : Beyond optics
  • Irungbam Padmabati : Khunung Eshei
  • A tribute to Arambam Somorendra
  • In quest of green vibes :: Poem
  • Workshop: Livelihood & Social Protection
  • Catering service as career option
  • Not yet an open revolt but not all well
  • Something more needed
  • Explain 'misleading' news, tells local daily
  • Chayom Thupki (Meetei Philosophy) #3
  • World Ocean Day 2019
  • Post election scenario : Manipur
  • ICC World Cup under the English Summer
  • Cry of a downtrodden State :: Poem
  • Yaithibi Loukol- violation of Land Act
  • Looking at politics of peace talk
  • Laija - Film Scenes #2 : eRang
  • Government Of India Stratagem
  • Love at Sunset :: Poem
  • Tips to make blood testing easy
  • IGNTU Seminar: Indo-Myanmar Relation
  • Budding Malwares in Manipur University
  • Aimol Baptist: Felicitation Program
  • Political uncertainty in Biren govt
  • Tangkhuls in traditions of Manipur #2
  • Imphal Jamboree- Improving state of youth
  • Zonel Sougaijam : Facebook Hall of Fame
  • Naga Peace Process :: News Timeline
  • Stop Station construction @Sagoltongba
  • Diploma at Don Bosco School, Kalimpong
  • Condemn firing incident at NDPP Sec Gen
  • The art of shuffling, reshuffling
  • Of our identity
  • Id-ul-Fitr @ Hatta #1 : Gallery
  • Tree plantation by Journalists : Gallery
  • Manipur textiles & handicrafts export
  • Phou-su Phou-su khol :: Poem
  • Nationalism in Manipuri literature #2
  • Training on Cyber Security
  • World Environment Day : Go Green Call
  • Environment Day and Manipur
  • Bamboo Cooking Competition : Gallery
  • Exploring Indigenous Knowledge : Book
  • Traditional environmental ethics
  • Air pollution : Focal theme of WED
  • Career options in Optometry
  • World Environment Day at Kumbi
  • I Want to Make Dingko Biopic : Shahid
  • Kwatha: Aayush to play an army officer
  • NSCN (K) must take NCA path: Tatmadaw
  • Cabinet to be reshuffled this month: CM
  • Dzukou valley declared 'plastic-free zone'
  • Modi will resolve Naga issue.. N'land BJP
  • Manipur - An Ethnic Dilemma #1
  • he UpaL :: Seireng
  • Cry of a Dying River - 79 :: Poem
  • The Killing Fields 2013-18 : News Timeline
  • World Environment Day, 2019
  • Time to 'beat air pollution'
  • Free Heart Scan at SKY Hospital
  • Nagaland CM on World Environment Day
  • 50 percent absence at Cabinet meet
  • Introspecting self for good of society
  • Lai Lamthokpa, Thangjing #2: Gallery
  • BEHS interacted with Guv: Gallery
  • India's Forest policy 2018 & concerns
  • Khoidajei- best Music Video Award @ SIFF
  • A constellation of Five :: Poem
  • A moral obligation for CSOs in election
  • BEHS, Motbung, students tour Raj Bhavan
  • Job @JCRE Skill Solutions
  • Ghost of 2001 not yet exorcised
  • Concern for a clean environment
  • Paoki Paddy Festival @Purul #2: Gallery
  • puNsi IceL :: Seireng
  • Meiraba : U-19 singles at All India Ranking
  • Modern village administration #1
  • Schoolchildren in the Park :: Poem
  • Tree Plantation at RIMS, Lamphelpat
  • First suspect always the husband
  • Gudui Ngai @ Kakhulong #2 : Gallery
  • Nationalism in Manipuri literature #1
  • Rain compelling ritual of Meiteis
  • Nehru to Modi: Profiles of PM : Book
  • Heart that reserved for destitute kids
  • Summer beauty tips & tricks for busy mom
  • The unintended fear psychosis
  • Urmila Shagolsem : Miss India : Gallery
  • Draft Indian Forest Act & impact on Manipur
  • Tobacco in Manipur and COTPA
  • End victimization of Research Scholars
  • Another opportunity missed for Congress
  • Failing to fear insecurities is strength
  • World No Tobacco Day observed
  • Striking regional balance : 2 from NE
  • RIMS again: Why ?
  • Chayom Thupki (Meetei Philosophy) #2
  • June Calendar for Year 2019 :: Tools
  • Heat wave advisory : Medical Directorate
  • Cry of a Dying River - 78 :: Poem
  • 1st Sports Event at Bengaluru
  • Election-Politics-Parties & Govt
  • 'Know Your Assam Rifle' violate UN Protocol
  • Modi in second stint as PM
  • BJP, Liberal & Mayang Settler in time of CAB
  • Amur falcon reaches breeding site in China
  • Tangkhuls in traditions of Manipur #1
  • Sinnaiba, Akhul, Amom :: eMing
  • Keibul Lamjao National Park : Gallery
  • Rise & Fall of Cachari Kingdom #2
  • Industry try to co-opt World No Tobacco Day
  • A new economic policy of Manipur
  • Gossips & rumours around 303 of BJP
  • Turmoil within the Congress
  • Heal the wound before it rots
  • Lai Lamthokpa, Thangjing #1: Gallery
  • How Modi & Shah decimated Congress
  • Public health Care :: Book Review
  • Finding Elopement :: Poem
  • Function of Nampou of Zeliangrongs #2
  • Public Health (MPH) at IIPH- Shillong
  • Spelling out pratical plans
  • Vocational Programs at BSDU, Jaipur
  • Injecting civic senses to citizens
  • Political development : Impact on Congress
  • Gudui Ngai @ Kakhulong #1 : Gallery
  • Chayom Thupki (Meetei Philosophy) #1
  • Excercise of adult franchise in LS Poll
  • Voices less heard - women candidates
  • Paramedical courses as career options #2
  • Manipur Traffic : A game of fast & furious
  • Rev William Pettigrew & Modern Education
  • Cheirao-chingkaba #3 : Gallery
  • Old-Kuki group by Linguistic Survey in 1904
  • A constellation of Five :: Poem
  • A free stopover at Amsterdam
  • Standing in queue for exam form at MU
  • Questions on the ceasefire coverage
  • Paoki Paddy Festival @Purul #1: Gallery
  • Status of Naga-Kuki relation in Manipur #2
  • There is no 3rd option between true & false
  • Global Warming- Climate change & effect
  • Summertime Blues :: Poem
  • Blocked heart valve treated without surgery
  • Reality of Education system in Manipur
  • Laichombam Sapana @ JNMDA : Gallery
  • Rise & Fall of Cachari Kingdom #1
  • Modi once again- Reading Election result
  • Function of Nampou of Zeliangrongs #1
  • Zhaoshomai, indigenous religion of Liiyai
  • Fashion by Kumarjit Laishram #2 : Gallery
  • Dams as a death trap in Manipur
  • Raju Bista (Kangpoki) is MP of Darjeeling
  • Pakhangba Cheng-hongba #1 : Gallery
  • Repeal AFSPA enacted on 22 May 1958
  • Future Hindu Culture of Meitei is magificient
  • Poumai Purul Paoki Fest : Gallery
  • AEgi KoHcY :: Seireng
  • 2019 HSLC Exam Toppers :: Gallery
  • HSLC Toppers share thoughts, aspirations
  • HSLC :: Top 25 Rank Holders
  • HSLC :: Subject Topper
  • HSLC :: Statistical Abstract
  • HSLC :: Full Roll No Listing
  • HSLC :: Compartmental
  • Mukna Kangjei Tournament : Gallery
  • Phayeng Koubru Haraoba #4 : Gallery
  • ELVEEGO : Top 10 Promising Companies
  • Hr Sec Exam 2019 Toppers #2: Gallery
  • Featured Front Page Photo 2019 #2: Gallery
  • Purnima Moirangthem : 5th in Commerce
  • Jiribam Bazaar :: 360 Panorama View
  • Thailand Princess @Kangla #2 :: Gallery
  • Kadigampou, Akeng :: eMing
  • Ningombam Tampha :: 3rd in ISC Exam
  • Cheiraoba Chak Katpa #2 :: Gallery
  • M Diana: National Women Social Award
  • Urmila Shagolsem: Miss India 2019 Finalist
  • Manipuri Calendar for 2019 : Download
  • SPONSORED ADS